HMGCR and hepatocellular carcinoma: Elevated activity of hydroxymethylglutaryl-coenzyme A reductase (HMGCR), the first enzyme of the mevalonate pathway, has been shown in a range of different tumors including hepatocellular carcinoma [3], leukemia [4] and lymphoma [5].